It was announced last week that that WuXi Vaccines, a subsidiary of WuXi Biologics, is planning to build a $240 million vaccine production facility on the newly established WuXi Biologics Campus in Dundalk, bringing 200 additional new jobs to the town over five years.
The new investment, for which a planning application was submitted to Louth County Council last month is being supported by the Irish Government through IDA Ireland will bring total employment on WuXi Biologics’ Dundalk Campus to 600 by 2024.
WuXi Vaccines is a joint venture between WuXi Biologics and Hile Bio-pharmaceutical. The company has entered into the strategic partnership with a global vaccine leader under which WuXi Vaccines will build a dedicated facility to supply a commercial product for the global market.
Speaking at this morning’s announcement in Dundalk, Minister for Business, Enterprise & Innovation, Heather Humphreys said, "I am delighted to announce 200 highly-skilled jobs in WuXi Vaccines, which is in addition to the 400 roles announced last year by WuXi Biologics for Dundalk. Without a doubt, this is a great win for the North-East and a huge vote of confidence in the local workforce."
WuXi Biologics Ireland Site Head and Vice President, Brendan McGrath added, "Dundalk’s potential to become a global hub for biologics contract manufacturing has moved one step closer to reality. As a leading global open-access biologics technology platform, WuXi Biologics’ global reach and operations currently counts most of the world’s leading biopharma companies."